PET-FDG: Impetus

Scar sarcoidosis on 18F-FDG PET/CT

18F-labeled fluoro-2-deoxyglucose positron emission tomography/ computed tomography (18F-FDG PET/CT) is an important imaging modality in the clinical workup of patients with chronic inflammatory disorders which present quite often with a fever of unknown origin. Sarcoidosis is a multisystem chronic inflammatory disorder with a wide clinical spectrum that can involve different organs. The diagno...

[ 18 F ] Fdg - Pet

FDG PET reimbursement.

Today, PET is increasingly accepted as a crucial imaging modality for early detection of disease, precise staging of disease progression, and accurate assessment of the effects of therapy. As the role of PET continues to emerge, so do questions regarding PET reimbursement. Understanding the complexities and complying with reimbursement policies, procedures, and interpretation of payer programs ...

FDG-PET in lymphoma

FDG-PET has changed lymphoma management at staging and for response assessment due to its capability to improve disease characterization and treatment selection. New recommendations have been made by the ICML working group in 2014. FDG-PET is now recommended for staging in the vast majority of lymphoma since almost all types of lymphoma are FDG-avid. It has been shown recently that FDG-PET due ...

FDG PET in Dementia

Positron emission tomography (PET) is a branch of Nuclear Medicine, a new novel way of functional imaging using radioisotopes, which has a significant role in all aspects of dementia-early diagnosis, differential diagnosis, and the assessment of drug treatment. [18F] Fluorodeoxyglucose (FDG) allows measurement of cerebral glucose metabolism both qualitatively and quantitatively. The metabolic a...